Atlas Trials

Strategic Transformation of the Market of HCV Treatments

Clinical trial NCT02961426 · UNKNOWN

Trial details

NCT number
NCT02961426
Sponsor
Drugs for Neglected Diseases
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatitis C
Start date
2016-09-01
Primary completion
2021-08-01
Enrollment
603

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.